Americans rushed to the hospital with heart attack symptoms have significantly higher rates of bleeding and transfusions after treatment.
Ads by Google
There is a large amount of evidence to support the beneficial effect of physical activity in the prevention of cardiovascular disease.
Physicians' prescription practices for drugs proven effective for treating heart disease has shown steady improvement over the past three years.
Pumps implanted into the chest to maintain circulation can significantly extend the lives of the sickest patients in end stage heart failure.
The findings should help physicians identify those patients who are at highest risk before heart surgery.
Medicare works to learn more about the use of implantable cardioverter defibrillators (ICDs) for primary prevention of sudden cardiac death.
Study shows great promise for treating adult heart failure.
The device is important given the rising concerns about potential cognitive impairments suffered by some patients undergoing open heart surgery.
The use of implanted defibrillators that keep the heart beating in proper electrical rhythm to prevent cardiac arrest appears to be cost effective.
The root causes of heart failure are not known, but the research found some drastic changes in the way muscle cells in the failing heart handle calcium.
Signs of heart failure may be in the blood and an enzyme, found in the blood, could be a potential marker for heart failure.
Patients With Heart Failure At Greatest Risk of Death Least Likely To Receive Appropriate Medications
Patients at greatest risk of death often are not prescribed ACE inhibitors that reduce the risk of death for patients with heart failure.
Loyola Researchers Discover Congestive Heart Failure Biological Marker Which Speeds Diagnosis, Treatment
A simple blood test can quickly identify what type of congestive heart failure (CHF) a patient has, improving diagnostic accuracy and enabling faster treatment.
Medication Reduces Risk of Heart Attack, Stroke and Cardiovascular Death Before and After Angioplasty
Use of the antiplatelet drug clopidogrel before a coronary angioplasty reduced the risk of cardiovascular death, heart attack or stroke within 30 days following the procedure.
Heart failure patients may receive a better treatment due to the new information that doctors have on the sequence of drugs given to heart failure patients.
The death rate for patients with congestive heart failure is 4 to 8 times that of the general population. The predominant causes of heart failure are hypertension and coronary heart disease.
Low hemoglobin levels are a predictor of increased risk of death and complications among heart failure patients.
Early diagnosis and new treatments can help battle heart failure.
About three out of four people diagnosed at a hospital with congestive heart failure were admitted for some other health condition.
Team says it has discovered the source of the heart arrhythmias to be transplantation of myoblasts.
Fewer front line medications exist for treating hospitalized patients with acute decompensated heart failure.
Emergency physicians are more likely to admit and order tests for patients with chest pain or other heart symptoms due to the fear of malpractice suits.
The findings may offer a new approach to the treatment of heart failure.
A drug, called daclizumab, is effective at reducing organ rejection and risk of infection in heart transplant patients.